2020-05-08FDA approves olaparib plus bevacizumab as maintenance treatment for ovarian, fallopian tube, or primary peritoneal cancersTrial DUO-ODrugs LYNPARZA (olaparib) · PARP inhibitor, bevacizumab · Anti-VEGFR antibodyConditionGynecologic
2018-06-13FDA approves bevacizumab in combination with chemotherapy for ovarian cancerDrugs Avastin (bevacizumab) · Anti-VEGFR antibody, carboplatin · Platinum agent, paclitaxel · TaxaneConditionGynecologic